Tag Archive for: Europe

The company said that the marketing authorization decision could come early next year.

The company announces a second UK-based office in Manchester and adds four new scientific and advertising principals to EMEA leadership team.

A major pharmaceutical rules overhaul, proposed by the European Commission in April, could see Europe’s share in global research and development contract by a third to 21% by 2040 translating to 2 billion euros ($2.15 billion) per year in lost investment, industry group EFPIA said today.

The safety panel reviewed data from Novo’s popular diabetes drug Ozempic and weight loss treatment Wegovy, which contain the same active ingredient, semaglutide.

The commission fined companies for participating in a cartel aimed at fixing the minimum price of an ingredient to produce the abdominal antispasmodic drug Buscopan and its generic versions.

Dengue fever will become a major threat in the southern United States, southern Europe and new parts of Africa this decade, the WHO’s chief scientist said, as warmer temperatures create the conditions for the mosquitoes carrying the infection to spread.

The Bloc is embarking on a global expansion journey, leveraging strategic acquisitions, joint ventures, and other growth strategies to unify and extend its brand, aiming to provide unparalleled service to clients worldwide. This plan is crafted to solidify The Bloc’s position as a premier global player, delivering top-tier health communications on an international scale.

European drugmakers warned that a proposed complete ban on substances known as PFAS or “forever chemicals” would render medicine production in the region impossible, part of a high-stakes wrangle between manufacturers and environmental regulators.

The world’s largest independent health agency cracks the code on authentic integration model for life-sciences clients across the region.

BioMarin Pharmaceutical Inc. announced that an individual in Germany with severe hemophilia A was treated with Roctavian (valoctocogene roxaparvovec-rvox), marking the first time that the gene therapy has been given commercially in Europe.